We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
-16.94%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.9B
AUM Growth
-$3.87B
Cap. Flow
-$755M
Cap. Flow %
-6.32%
Top 10 Hldgs %
21.67%
Holding
1,534
New
61
Increased
492
Reduced
593
Closed
262

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$59.4M
2
BABA icon
Alibaba
BABA
+$52.4M
3
UNH icon
UnitedHealth
UNH
+$43.7M
4
ABT icon
Abbott
ABT
+$42.2M
5
AGN
Allergan plc
AGN
+$40.4M

Sector Composition

Rank Sector Weight
1 Technology 23.72%
2 Healthcare 19.62%
3 Financials 12.72%
4 Consumer Discretionary 10.57%
5 Communication Services 7.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFF icon
301
International Flavors & Fragrances
IFF
$20.3B
$7.2M 0.06%
70,519
+9,494
+16% +$1.18M
L icon
302
Loews
L
$24.5B
$7.17M 0.06%
205,735
-35,624
-15% -$1.68M
VIPS icon
303
Vipshop
VIPS
$7.26B
$7.09M 0.06%
455,295
-83,521
-16% -$1.19M
CTVA icon
304
Corteva
CTVA
$60.5B
$7.08M 0.06%
301,041
+17,347
+6% +$477K
GNTX icon
305
Gentex
GNTX
$5.1B
$7.04M 0.06%
317,738
+4,124
+1% +$115K
RTN
306
DELISTED
Raytheon Company
RTN
$6.95M 0.06%
53,016
+22,788
+75% +$4.51M
FCN icon
307
FTI Consulting
FCN
$5.14B
$6.78M 0.06%
56,592
-18,053
-24% -$2.12M
EA icon
308
Electronic Arts
EA
$52.7B
$6.77M 0.06%
67,589
+37,751
+127% +$3.97M
BIO icon
309
Bio-Rad Laboratories Class A
BIO
$8.76B
$6.76M 0.06%
19,292
+17,723
+1,130% +$6.52M
PWR icon
310
Quanta Services
PWR
$84.2B
$6.74M 0.06%
212,313
-323,681
-60% -$12M
EQH icon
311
Equitable Holdings
EQH
$13.2B
$6.74M 0.06%
466,080
+129,636
+39% +$2.83M
PHM icon
312
Pultegroup
PHM
$25.2B
$6.72M 0.06%
301,101
-61,987
-17% -$2.39M
SBNY
313
DELISTED
Signature Bank
SBNY
$6.69M 0.06%
83,264
-100,062
-55% -$12.6M
ZION icon
314
Zions Bancorporation
ZION
$10.1B
$6.69M 0.06%
250,001
+9,582
+4% +$395K
ADM icon
315
Archer Daniels Midland
ADM
$38.7B
$6.67M 0.06%
189,617
+17,680
+10% +$723K
MOH icon
316
Molina Healthcare
MOH
$10.4B
$6.66M 0.06%
47,687
-14,940
-24% -$2M
AME icon
317
Ametek
AME
$53.9B
$6.66M 0.06%
92,477
-47,098
-34% -$4.25M
EQC
318
DELISTED
Equity Commonwealth
EQC
$6.64M 0.06%
209,543
-72,233
-26% -$2.31M
HDS
319
DELISTED
HD Supply Holdings, Inc.
HDS
$6.6M 0.06%
232,071
+199,859
+620% +$7.46M
AIG icon
320
American International
AIG
$42.5B
$6.48M 0.05%
267,029
-32,678
-11% -$1.4M
CERN
321
DELISTED
Cerner Corp
CERN
$6.46M 0.05%
102,613
+75,336
+276% +$5.36M
REXR icon
322
Rexford Industrial Realty
REXR
$8.63B
$6.43M 0.05%
156,857
-139,393
-47% -$6.41M
SCHW
323
Charles Schwab
SCHW
$182B
$6.42M 0.05%
190,932
+78,389
+70% +$3.29M
VMC icon
324
Vulcan Materials
VMC
$36.8B
$6.41M 0.05%
59,270
+44,338
+297% +$5.66M
NKTR icon
325
Nektar Therapeutics
NKTR
$2.39B
$6.4M 0.05%
23,902
-7,072
-23% -$2.19M

Similar funds

KBC Group's Q1 2020 Portfolio in Review

As of Q1 2020, KBC Group held 1,534 positions worth $11.9B, down 24% from $15.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

KBC Group withdrew a net $755M in Q1 2020, closing 262 positions and reducing 593 holdings. Its most notable exit was TransDigm Group, an estimated $18M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, KBC Group opened a new position in Ingersoll Rand worth $12.3M.

  • KBC Group's largest Q1 2020 buy was Ingersoll Rand: 495,850 shares worth $12.3M.
  • KBC Group added most to Medtronic in Q1 2020, an estimated $59.4M increase.
  • KBC Group's biggest Q1 2020 reduction was Alphabet (Google) Class A, cutting an estimated $59.1M.
  • KBC Group fully exited TransDigm Group in Q1 2020, selling an estimated $18M.
  • KBC Group's ten largest holdings make up 22% of its $11.9B portfolio in Q1 2020.
  • KBC Group opened 61 new positions and closed 262 in Q1 2020.
  • KBC Group's portfolio value fell 24% quarter-over-quarter to $11.9B.

Based on KBC Group's 13F filing for Q1 2020, filed 4 May 2020.